 |
市場調查報告書
商品編碼
1629684
眩暈治療市場按類型、治療方法、給藥途徑、最終用戶和地區分類Vertigo Treatments Market, By Type, By Treatment, By Route of Administration, By End User, By Geography |
||||||
2024 年全球眩暈治療市場規模估計為 15.3 億美元，預計 2031 年將達到 22.4 億美元，2024 年至 2031 年的複合年成長率為 5.6%。
| 報告範圍 | 報告詳細資訊 | ||
|---|---|---|---|
| 基準年 | 2023 | 2024 年的市場規模 | 15.3億美元 |
| 效能資料 | 2019 年至 2023 年 | 預測期 | 2024 年至 2031 年 |
| 預測期間 2024 年至 2031 年複合年成長率： | 5.60% | 2031 年價值預測 | 22.4億美元 |
頭暈是一種感覺自己或周圍環境在移動或旋轉的狀態，即使這種感覺是靜止的。這通常是由於內耳不平衡引起的。人口老化是導致主要市場頭暈盛行率上升的重要因素。根據美國國家醫學圖書館 2023 年 6 月的估計，超過 12% 的 60 歲以上的成年人在一生中的某個時刻會出現頭暈症狀。治療頭暈的治療方法有很多種，包括藥物治療、前庭復健治療、平衡再教育計畫和手術治療。診斷技術的進步和新型治療劑的引入正在支持市場擴張。
市場動態：
老年人口的增加、引起頭暈的神經系統疾病病例的增加以及新產品的核准和推出是推動全球頭暈治療市場發展的一些主要因素。然而，與手術治療相關的風險、與眩暈相關的社會恥辱以及品牌藥物的高成本是限制市場成長的一些挑戰。從機會角度來看，未經治療的頭暈給全世界帶來了沉重的經濟負擔。開發中國家醫療旅遊業的發展和頭暈管理設備的技術發展為市場參與者提供了寶貴的視角。醫療設備創新者和醫療保健提供者之間的合作可以幫助更有效地解決未滿足的需求。
本研究的主要特點
本報告對全球眩暈治療市場進行了詳細分析，並以 2023 年為基準年，給出了預測期（2024-2031 年）的市場規模和年複合成長率（CAGR%）。
它還強調了各個領域的潛在商機，並說明了該市場的引人注目的投資提案矩陣。
它還提供了關於市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的主要考察。
它根據公司亮點、產品系列、關鍵亮點、業績和策略等參數列出了全球眩暈治療市場的主要企業簡介。
主要公司包括美敦力雅培實驗室、西門子醫療、強生、奧迪康、科利耳有限公司、Auris Medical Holding AG、Otonomy, Inc.、Sensorion SA、Sound Pharmaceuticals Inc.、葛蘭素史克 (GSK)、默克公司、輝瑞耳公司、諾華公司和拜耳公司。
本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球眩暈治療市場報告涉及該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
相關人員將透過用於分析全球眩暈治療市場的各種策略矩陣更輕鬆地做出決策。
目錄
第1章 調查目的與前提條件
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告描述
- 市場定義和範圍
- 執行摘要
第3章市場動態、法規與趨勢分析
- 市場動態
- 影響分析
- 主要進展
- 監管情景
- 產品發布/核准
- PEST分析
- PORTER 分析
- 併購情景
- 產業趨勢
4. 2019 年至 2031 年全球眩暈治療市場（按類型）
- 中樞性眩暈
- 周圍性眩暈
5. 全球眩暈治療市場，依治療方法，2019-2031 年
- 藥品
- 抗膽鹼能藥物
- 抗組織胺藥
- 苯二氮平類
- 其他
- 手術/治療
6. 2019 年至 2031 年按給藥途徑分類的全球眩暈治療市場
- 口服
- 外用
- 腸外
- 其他
7. 全球眩暈治療市場，依最終使用者分類，2019 年至 2031 年
- 醫院
- 診所
- 其他
8. 2019 年至 2031 年全球眩暈治療市場（按地區分類）
- 北美洲
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
- 非洲
第9章 競爭格局
- Medtronic
- Abbott Laboratories
- Siemens Healthineers
- Johnson & Johnson
- Oticon
- Cochlear Limited
- Auris Medical Holding AG
- Otonomy, Inc.
- Sensorion SA
- Sound Pharmaceuticals, Inc.
- GSK（GlaxoSmithKline）
- Merck & Co.
- Pfizer Inc.
- Novartis AG
- Bayer AG
第 10 章分析師建議
- 命運之輪
- 分析師觀點
- 一致的機會圖
第 11 章 參考文獻與調查方法
- 參考
- 調查方法
- 關於出版商
The global vertigo treatments market is estimated to be valued at USD 1.53 Bn in 2024 and is expected to reach USD 2.24 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.6% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 1.53 Bn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
| Forecast Period 2024 to 2031 CAGR: | 5.60% | 2031 Value Projection: | US$ 2.24 Bn |
Vertigo refers to a condition where a person feels as if they or everything around them is moving or spinning, even though they are stationary. It is typically caused due to imbalance in the inner ear. Aging population has contributed greatly to the rising prevalence of vertigo across major markets. According to the National Library of Medicine estimates in June 2023, over 12% of adults aged 60 years and above experience vertigo at least once in their lifetime. Various treatment options are available for vertigo including medications, vestibular rehabilitation therapy, balance retraining programs, surgical treatments, etc. Advancements in diagnosis and introduction of novel therapeutics are supporting the market expansion.
Market Dynamics:
Rising geriatric populace, growing cases of neurological disorders causing vertigo, and new product approvals and launches are some of the key factors driving the global vertigo treatments market. However, risks associated with surgical treatments, social stigma around vertigo and high costs of branded therapies are certain challenges restraining the market growth. On the opportunities side, untreated vertigo imposes a huge economic burden globally. Growing medical tourism in developing nations and technological developments in vertigo management devices present valuable prospects for market players. Collaborations between medical device innovators and healthcare providers can help address unmet needs more effectively.
Key Features of the Study:
This report provides in-depth analysis of the global vertigo treatments market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global vertigo treatments market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Medtronic Abbott Laboratories, Siemens Healthineers, Johnson & Johnson, Oticon, Cochlear Limited, Auris Medical Holding AG, Otonomy, Inc., Sensorion SA, Sound Pharmaceuticals Inc., GSK (GlaxoSmithKline), Merck & Co., Pfizer Inc., Novartis AG, and Bayer AG
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global vertigo treatments market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vertigo treatments market
Market Segmentation
- By Type Insights (Revenue, USD Bn, 2019 - 2031)
- Central Vertigo
- Peripheral Vertigo
- By Treatment Insights (Revenue, USD Bn, 2019 - 2031)
- Medication
- Anticholinergics
- Antihistamines
- Benzodiazepines
- Others
- Surgery/Therapy
- By Route of Administration Insights (Revenue, USD Bn, 2019 - 2031)
- Oral
- Topical
- Parenteral
- Others
- By End User Insights (Revenue, USD Bn, 2019 - 2031)
- Hospitals
- Clinics
- Others
- Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Medtronic
- Abbott Laboratories
- Siemens Healthineers
- Johnson & Johnson
- Oticon
- Cochlear Limited
- Auris Medical Holding AG
- Otonomy, Inc.
- Sensorion SA
- Sound Pharmaceuticals, Inc.
- GSK (GlaxoSmithKline)
- Merck & Co.
- Pfizer Inc.
- Novartis AG
- Bayer AG
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Vertigo Treatments Market, By Type
- Global Vertigo Treatments Market, By Treatment
- Global Vertigo Treatments Market, By Route of Administration
- Global Vertigo Treatments Market, By End User
- Global Vertigo Treatments Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Vertigo Treatments Market, By Type, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Central Vertigo
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Peripheral Vertigo
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Global Vertigo Treatments Market, By Treatment, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Medication
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Anticholinergics
- Antihistamines
- Benzodiazepines
- Others
- Surgery/Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Vertigo Treatments Market, By Route of Administration, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Vertigo Treatments Market, By End User, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Vertigo Treatments Market, By Region, 2019 - 2031, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Treatment, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Oticon
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cochlear Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Auris Medical Holding AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Otonomy, Inc.
- Sensorion SA
- Sound Pharmaceuticals, Inc.
- GSK (GlaxoSmithKline)
- Merck & Co.
- Pfizer Inc.
- Novartis AG
- Bayer AG
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
